The United States has bought nearly the entire world’s supply of remdesivir, one of just two drugs proven to treat COVID-19.
The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.
The announcement from the US Department of Health and Human Services (HHS) implies European health authorities may not be able to acquire any supplies until the autumn.
Euronews has contacted EMA
Continue Reading on Citi news